Skip to main content
. 2023 Jul 20;12(8):e220165. doi: 10.57264/cer-2022-0165

Figure 4. . Relative efficacy and SUCRA of the endoscopic healing rates among patients with grade C/D at (A & B) 4 and (C & D) 8 weeks.

Figure 4. 

Figure 4. 

PPI: Proton pump inhibitors; VPZ5: Vonoprazan 5 mg; VPZ10: Vonoprazan 10 mg; VPZ20: Vonoprazan 20 mg; VPZ40: Vonoprazan 40 mg; TEAEs: Treatment-emergent adverse events; SUCRA: The surface under the cumulative ranking.